Profile
Matthew Gall is currently Chief Financial Officer at Tango Therapeutics, Inc. since 2026.
Formerly, Mr. Gall was Chief Financial Officer & Treasurer at Kalaris Therapeutics, Inc. from 2025 to 2026, Chief Financial Officer at iTeos Therapeutics, Inc. from 2020 to 2025, and Senior Vice President-Corporate Development at Sarepta Therapeutics, Inc. from 2014 to 2020.
Education includes an undergraduate degree from Bowling Green State University and an MBA from The University of Chicago Booth School of Business.
Matthew Gall active positions
| Companies | Position | Start |
|---|---|---|
| TANGO THERAPEUTICS, INC. | Director of Finance/CFO | 15/04/2026 |
Former positions of Matthew Gall
| Companies | Position | End |
|---|---|---|
| ITEOS THERAPEUTICS, INC. | Director of Finance/CFO | 28/08/2025 |
| SAREPTA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/06/2020 |
Training of Matthew Gall
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Bowling Green State University
Bowling Green State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Chicago Booth School of Business
The University of Chicago Booth School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
iTeos Therapeutics, Inc.
iTeos Therapeutics, Inc. BiotechnologyHealth Technology Develops immunomodulators for cancer treatments | Health Technology |
Tango Therapeutics, Inc.
Tango Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company that engages in discovering and delivering precision cancer medicines | Health Technology |
- Stock Market
- Insiders
- Matthew Gall
















